Diabetes & Metabolism Journal

CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Clinical Characteristics and Metabolic Predictors of Rapid Responders to Dipeptidyl Peptidase-4 Inhibitor as an Add-on Therapy to Sulfonylurea and Metformin

Ye An Kim, Won Sang Yoo, Eun Shil Hong, Eu Jeong Ku, Kyeong Seon Park, Soo Lim, Young Min Cho, Kyong Soo Park, Hak Chul Jang, Sung Hee Choi

Diabetes Metab J. 2015;39(6):489-497. Published online November 27, 2015
DOI: https://doi.org/10.4093/dmj.2015.39.6.489

Clinical Characteristics and Metabolic Predictors of Rapid Responders to Dipeptidyl Peptidase-4 Inhibitor as an Add-on Therapy to Sulfonylurea and Metformin

Ye An Kim, Won Sang Yoo, Eun Shil Hong, Eu Jeong Ku, Kyeong Seon Park, Soo Lim, Young Min Cho, Kyong Soo Park, Hak Chul Jang, Sung Hee Choi

Diabetes & Metabolism Journal. 2015;39(6):489

Link1 Link2 Link3

Choosing Dipeptidyl Peptidase-4 Inhibitors, Sodium-glucose Cotransporter-2 Inhibitors, or Both, as Add-ons to Metformin: Patient Baseline Characteristics Are Crucial

Ronald M. Goldenberg

Clinical Therapeutics. 2017;39(12):2438-2447

Link1 Link2

Treatment progression in sulfonylurea and dipeptidyl peptidase-4-inhibitor cohorts of type 2 diabetes patients on metformin

Xiaomei Peng, Dingfeng Jiang, Dongju Liu, Oralee Varnado, Jay Bae

Patient Preference and Adherence. 2016;Volume 10:1539-1546

Link1

Combination Therapy with a Dipeptidyl peptidase-4 Inhibitor, Sulfonylurea, and Metformin Markedly Improves HbA_1c Levels in Japanese Patients with Type 2 Diabetes Mellitus

Koichi Hirao, Hajime Maeda, Shin-ichiro Shirabe, Ritsuko Yamamoto, Tetsuyuki Hirao, Setsuko Hirao, Mikio Yamauchi, Keiko Arai

Japanese Clinical Medicine. 2012;3:JCM.S8571

Link1 Link2 Link3

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor PF-734200 added to metformin in Type 2 diabetes

J. Rosenstock, A. J. Lewin, P. Norwood, V. Somayaji, T. T. Nguyen, J. G. Teeter, S. L. Johnson, H. Dai, S. G. Terra

Diabetic Medicine. 2011;28(4):464-469

Link1 Link2

Differential Cardiovascular Outcomes after Dipeptidyl Peptidase-4 Inhibitor, Sulfonylurea, and Pioglitazone Therapy, All in Combination with Metformin, for Type 2 Diabetes: A Population-Based Cohort Study

Jong-Mi Seong, Nam-Kyong Choi, Ju-Young Shin, Yoosoo Chang, Ye-Jee Kim, Joongyub Lee, Ju-Young Kim, Byung-Joo Park

PLOS ONE. 2015;10(5):e0124287

Link1

Response to Letter Regarding Article, “Cardiovascular Outcomes Comparison of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylurea as Add-on Therapy for Type 2 Diabetes Mellitus: a Meta-Analysis”

Kyung Woo Park

Journal of Lipid and Atherosclerosis. 2022;11(1):87

Link1 Link2 Link3

Sodium Glucose Cotransporter-2 Inhibitors as an Add-on Therapy to Metformin Plus Dipeptidyl Peptidase-4 Inhibitor in Patients with Type 2 Diabetes

Jaehyun Bae, Young-eun Kim, Minyoung Lee, Yong-ho Lee, Byung-Wan Lee, Bong-Soo Cha, Eun Seok Kang

Yonsei Medical Journal. 2022;63(6):539

Link1 Link2 Link3

Letter by Awadhesh Kumar Singh Regarding Article, “Cardiovascular Outcomes Comparison of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylurea as Add-on Therapy for Type 2 Diabetes Mellitus: a Meta-Analysis”

Awadhesh Kumar Singh, Ritu Singh

Journal of Lipid and Atherosclerosis. 2022;11(1):84

Link1 Link2 Link3

Cardiovascular Outcomes Comparison of Dipeptidyl Peptidase-4 Inhibitors versus Sulfonylurea as Add-on Therapy for Type 2 Diabetes Mellitus: a Meta-Analysis

Won Kyeong Jeon, Jeehoon Kang, Hyo-Soo Kim, Kyung Woo Park

Journal of Lipid and Atherosclerosis. 2021;10(2):210

Link1 Link2 Link3